Elevated presence of iNKT cells in AAA had been also found in Apoe-/- mice infused with Ang II, especially after the treatment with α-galactosylceramide (αGC), a synthetic glycolipid that activates iNKT cells via CD1d. The gene discussed is AGT; the disease is triple-A syndrome.